Immuneering Corp. (IMRX)

5.33 +0.35 (+7.03%) USD  |  NASDAQ  |  Mar 06, 16:00
5.315 -0.02 (-0.28%) After-Hours: 20:00
More

Immuneering Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for IMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Verastem, Inc. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade